Smithtown Assisted Living
(516) 265-7793
JAK1/2 Inhibitor Baricitinib Eases DMARD-refractory RA (CME/CE)
(MedPage Today) -- Induced 62% clinical response and slowed radiographic progression
via
JAK1/2 Inhibitor Baricitinib Eases DMARD-refractory RA (CME/CE)
by
Newer Post
Older Post
Home